Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China.
OBJECTIVE
To investigate the association among XRCC1 polymorphisms, smoking, drinking and the risk of prostate cancer (PCa) in men from Han, Southern China.


METHODS
In a case-control study of 207 patients with PCa and 235 cancer-free controls, frequency-matched by age, we genotyped three XRCC1 polymorphisms (codons 194, 280 and 399) using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RELP) method.


RESULTS
Among the three polymorphisms, we found that the XRCC1 Arg399Gln variant allele was associated with increased PCa risk (adjusted odd ratio [OR]: 1.67, 95% confident interval [CI]: 1.11-2.51), but the XRCC1 Arg194Trp variant allele had a 38% reduction in risk of PCa (adjusted OR: 0.62, 95% CI: 0.41-0.93). However, there was no significant risk of PCa associated with Arg280His polymorphism. When we evaluated the three polymorphisms together, we found that the individuals with 194Arg/Arg wild-type genotype, Arg280His and Arg399Gln variant genotypes had a significantly higher risk of PCa (adjusted OR: 4.31; 95% CI: 1.24-14.99) than those with three wild-type genotypes. In addition, we found that Arg399Gln variant genotypes had a significant risk of PCa among heavy smokers (adjusted OR: 2.04; 95% CI: 1.03-4.05).


CONCLUSIONS
These results suggest that polymorphisms of XRCC1 appear to influence the risk of PCa and may modify risks attributable to environmental exposure.
Xu
Zheng
Z
Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Hua
Li-Xin
LX
Qian
Li-Xin
LX
Yang
Jie
J
Wang
Xin-Ru
XR
Zhang
Wei
W
Wu
Hong-Fei
HF
D000230:Adenocarcinoma / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D000368:Aged; D002681:China / Q000453:epidemiology; D004268:DNA-Binding Proteins / Q000097:blood / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D016017:Odds Ratio; D012150:Polymorphism, Restriction Fragment Length; D011471:Prostatic Neoplasms / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D000076105:X-ray Repair Cross Complementing Protein 1
D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human